Cryoablation is a modern treatment technology that uses extremely low temperatures to destroy cancer cells. Currently, cryoablation systems use two main methods to generate the freezing effect, based on their mechanisms of action: inert gases such as argon or helium, and liquid nitrogen. Both methods are considered safe and provide comparable treatment effectiveness.
Cryoablation is performed by an interventional radiologist, who uses ultrasound and/or computed tomography (CT scan) to guide the procedure. This allows the cryoprobe to be inserted precisely and safely into the tumor without the need for a surgical incision.
The cryoprobe is the key device used in the treatment. It is a very small needle, approximately the size of a pen tip. Once inserted into the tumor, it delivers extremely low temperatures to destroy the targeted cancer cells.
With image-guided medical technology and newer, smaller cryoprobes, the wound following treatment is very small, approximately the size of a needle puncture. In general, the wound gradually heals on its own within approximately 3–5 days.






Cryoablation is suitable for patients with tumors or cancerous masses approximately 2–4 centimeters in size that can be visualized using ultrasound. This allows the doctor to plan and perform the treatment accurately.
In general, cryoablation is performed only once, as the targeted tumor or cancer cells are destroyed by extremely low temperatures during the procedure. However, the number of treatments required may vary depending on the size, location, and characteristics of the tumor, as well as the treating doctor's judgment.
articles